POAI Projected Dividend Yield

Predictive Oncology Inc ( NASDAQ : POAI )

Predictive Oncology is focused on applying artificial intelligence (AI) to support the development of optimal cancer therapies. Co. operates in four primary business areas: the application of AI for drug-response predictions within an experimental space that enables an informed selection of drug/tumor combinations; the creation and development of tumor-specific 3D cell culture models driving prediction of drug response with correlation to clinical response; the contract services and research focused on solubility improvements, stability studies, and protein production; and the production of the STREAMWAY® System for automated, direct-to-drain medical fluid disposal and associated products.

20 YEAR PERFORMANCE RESULTS